3E043GRIntroduction of Other Therapeutic Monoclonal Antibody into Central Vein, Percutaneous Approach

  • Billable / Specific Code
ICD-10-PCS 3E043GR
CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.FacebookXLinkedInPrint

3E043GR is a billable ICD-10-PCS procedure code for Introduction of Other Therapeutic Monoclonal Antibody into Central Vein, Percutaneous Approach. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

Code Identity

ICD-10-PCS Code
3E043GR
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Other Therapeutic Monoclonal Antibody into Central Vein, Percutaneous Approach
Parent Code
Short Description
Introduce Oth Rx Moncln Ab in Central Vein, Perc

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1Section3Administration
2Body SystemEPhysiological Systems and Anatomical Regions
3Operation0Introduction
4BodySystem/Region4Central Vein
5Approach3Percutaneous
6SubstanceGOther Therapeutic Substance
7QualifierROther Therapeutic Monoclonal Antibody

Code History

Replaces previously assigned code(s):
  • XW043A3 — Introduce Bezlotoxumab in Central Vein, Perc, New Tech 3
Replaced in the FY 2026 code set by:
  • XW043MA — Introduce Emapalumab-lzsg in Central Vein, Perc, New Tech 1

Similar Procedure Codes

Questions About 3E043GR

Is 3E043GR a billable code?

Yes. 3E043GR is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Other Therapeutic Monoclonal Antibody into Central Vein, Percutaneous Approach on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in 3E043GR mean?

3E043GR breaks down character by character: the 1st character 3 is the Section (Administration); the 2nd character E is the Body System (Physiological Systems and Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 4 is the BodySystem/Region (Central Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character G is the Substance (Other Therapeutic Substance); the 7th character R is the Qualifier (Other Therapeutic Monoclonal Antibody).